{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:01:07Z","timestamp":1780401667719,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1016\/s0002-9394(02)01820-2","type":"journal-article","created":{"date-parts":[[2002,12,10]],"date-time":"2002-12-10T16:00:31Z","timestamp":1039536031000},"page":"863-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure"],"prefix":"10.1016","volume":"134","author":[{"given":"Henry D","family":"Jampel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Bacharach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-pui","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G","family":"Wohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred M","family":"Solish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9394(02)01820-2_BIB1","first-page":"429","article-title":"Advanced Glaucoma Intervention Study (AGIS)","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9394(14)76896-5","article-title":"Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma","volume":"111","author":"Mao","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1001\/archopht.1980.01020040416003","article-title":"Clinical evaluation of nerve fiber layer atrophy as an indicator of glaucomatous optic nerve damage","volume":"98","author":"Quigley","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archopht.1982.01030030137016","article-title":"Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy","volume":"100","author":"Quigley","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.80.5.389","article-title":"Number of people with glaucoma worldwide","volume":"80","author":"Quigley","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJM199810293391808","article-title":"Medical management of glaucoma","volume":"339","author":"Alward","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-3768.1972.tb05954.x","article-title":"Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm\u2014an attempt to localize the main resistance to outflow of aqueous humor in man","volume":"50","author":"Bill","year":"1972","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0161-6420(83)34492-4","article-title":"Why is intraocular pressure elevated in chronic simple glaucoma? Anatomical considerations","volume":"90","author":"Rohen","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archopht.1966.03850010495006","article-title":"Acetazolamide and outflow facility","volume":"76","author":"Galin","year":"1966","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/exer.1998.0508","article-title":"Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections","volume":"67","author":"Ocklind","year":"1998","journal-title":"Exp Eye Res"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(93)31484-3","article-title":"Effects of PhXA41, a new prostaglandin F2\u03b1 analog, on aqueous dynamics in human eyes","volume":"100","author":"Toris","year":"1993","journal-title":"Ophthalmology"},{"issue":"Suppl 2","key":"10.1016\/S0002-9394(02)01820-2_BIB12","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0039-6257(97)80010-0","article-title":"Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function","volume":"41","author":"Toris","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB13","first-page":"623","article-title":"Timolol and facility of outflow","volume":"16","author":"Zimmerman","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00002512-199914050-00006","article-title":"Prostaglandin analogues in the treatment of glaucoma","volume":"14","author":"Lind\u00e9n","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB15","first-page":"315","article-title":"Prostaglandin F2\u03b1 receptors in the human trabecular meshwork","volume":"39","author":"Anthony","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB16","first-page":"236","article-title":"Pharmacological characterization of prostaglandin-related ocular hypotensive agents","volume":"38","author":"Goh","year":"1994","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jop.1996.12.489","article-title":"Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits","volume":"12","author":"Taniguchi","year":"1996","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB18","first-page":"3193","article-title":"Mechanisms of action of unoprostone on trabecular meshwork contractility","volume":"42","author":"Thieme","year":"2001","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1185\/03007999909113368","article-title":"A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2\u03b1 metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension","volume":"15","author":"Nordmann","year":"1999","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB22","first-page":"514","article-title":"Double-masked comparative study of UF-021 and timolol ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension","volume":"37","author":"Azuma","year":"1993","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9394(00)00943-0","article-title":"A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension","volume":"131","author":"Aung","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00061198-200112000-00009","article-title":"A comparison of intraocular pressure-lowering effect of prostaglandin F2-\u03b1 analogues, latanoprost, and unoprostone isopropyl","volume":"10","author":"Kobayashi","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9394(01)01096-0","article-title":"Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma","volume":"132","author":"Saito","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0161-6420(00)00495-4","article-title":"A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension","volume":"108","author":"Susanna","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB27","unstructured":"Center for Drug Evaluation and Research New and Generic Drug Approvals: 1998\u20132002. Comparison of the effects of different concentrations of unoprostone isopropylate ophthalmic solution on intraocular pressure in subjects with primary open angle glaucoma or ocular hypertension. Available at: http:\/\/www.fda.gov\/cder\/foi\/nda\/2000\/21214_Rescula_medr_P1.pdf; http:\/\/www.fda.gov\/cder\/foi\/nda\/2000\/21214_Rescula_medr_P2.pdf. Accessed on March 29, 2002."},{"key":"10.1016\/S0002-9394(02)01820-2_BIB28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(01)01337-X","article-title":"A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data","volume":"133","author":"Nordmann","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9394(00)00824-2","article-title":"Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%","volume":"131","author":"Stewart","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01820-2_BIB30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0002-9394(01)01101-1","article-title":"Additive efficacy of isopropyl 0.12%","volume":"132","author":"Alward","year":"2001","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402018202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402018202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:30:30Z","timestamp":1757593830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939402018202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S0002939402018202"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9394(02)01820-2","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9394(02)01820-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}